Genetic Testing

275 Million New Genetic Variants Identified in “All of Us” Dataset

February 20, 2024 - Researchers have identified over 275 million previously unreported genetic variants within the National Institutes of Health’s All of Us Research Program dataset, which may provide additional insights into the genomic drivers of health and disease. The findings, published this week in Nature, may help advance genomic research for...


More Articles

Precision Medicine Tool May Accurately Predict Bariatric Surgery Outcomes

by Shania Kennedy

Researchers from the University at Buffalo (UB) have demonstrated that a tool originally designed to predict a patient’s risk level for various addictions using genetic and psychosocial factors...

Research Identifies Link Between Genetic Makeup and Disease Risk

by Mark Melchionna

Using data from the UCLA ATLAS Precision Health Biobank, UCLA Health researchers found differences in diagnoses, hospital use, and genetic disease across various populations, which provided them with a...

Precision Medicine Approach May Improve Prostate Cancer Screening

by Shania Kennedy

Researchers from Stanford Medicine have developed a precision medicine approach that may help flag and separate normal variations in prostate-specific antigen (PSA) caused by genetic factors unrelated...

All of Us Research Program Returns Genetic Results to Participants

by Shania Kennedy

The National Institutes of Health's (NIH) All of Us Research Program announced that it has begun returning personalized health-related DNA results to more than 155,000 participants, detailing each...

Limited Racial Data Curbs Diagnosis, Treatment of Genetic Conditions

by Mark Melchionna

Researchers from the Johns Hopkins Medicine Hereditary Hemorrhagic (HHT) Center concluded that limited racial and ethnic data likely contributes to inaccurate diagnoses and treatment of rare genetic...

NIH Researchers Develop Personalized Breast Cancer Therapy Approach

by Erin McNemar, MPA

National Cancer Institute researchers have revealed an experimental form of immunotherapy that uses a patient’s tumor-fighting immune cells to treat those with metastatic breast cancer, advancing...

Blood Biomarkers Can Help Determine Post-Pregnancy Depression 

by Erin McNemar, MPA

Michigan-based researchers found that signs of inflammation in blood could predict and identify severe depression during and after pregnancy, promoting precision medicine efforts. By...

Data Analysis Reveals Genes Linked to Rare Respiratory Disease

by Erin McNemar, MPA

According to a large data analysis by the Indiana University School of Medicine, the rare respiratory disease called primary ciliary dyskinesia (PCD) is more common than previously thought. The data...

Using Biomarkers to Prevent, Cure Neurological Disorders   

by Erin McNemar, MPA

To better understand why so many individuals worldwide suffer from brain diseases, Cleveland Clinic has launched a new study aiming to identify disease biomarkers early, preventing...

Gene Inhibiting Assists Chronic Disease Prevention, Targeted Therapy 

by Erin McNemar, MPA

According to researchers from Massachusetts General Hospital, an olfactory receptor gene that aids in the sense of smell could play a role in the metastasis of breast cancer to the brain. By inhibiting...

Machine Learning Helps Repair Genetic Damage

by Erin McNemar, MPA

Using machine learning techniques, researchers from Massachusetts General Hospital and the National Cancer Research Centre, have discovered how to repair genetic damage to prevent DNA...

Genetic Mutation Data Indicates Ovarian Cancer Risk 

by Erin McNemar, MPA

Cedars Sinai scientists have found the origins of a common ovarian cancer by modeling fallopian tube tissue, allowing physicians to determine how genetic mutations increase an individual’s...

Machine Learning Identifies Genetic Mutations for Spinal Disorder 

by Erin McNemar, MPA

Weill Cornell Medicine researchers are using machine learning to study genetic mutations associated with spina bifida.   According to senior author and director of the Center for...

Identifying Genetic Mutations Can Advance Precision Medicine Efforts

by Erin McNemar, MPA

By studying genetic mutations in patients with schizophrenia, researchers can identify disease-associated genetic variants, paving the way for precision medicine. The research was conducted...

Diverse Genome Sequences Lead to Creation of Risk Scores

by Erin McNemar, MPA

By studying diverse populations, researchers found genetic variants associated with blood lipid levels and created a polygenic risk score to predict elevated low-density lipoprotein cholesterol...

Deep Learning Analyzes Genetics For Aortic Aneurysm Risk

by Erin McNemar, MPA

To identify patients at high risk of aortic aneurysm, Massachusetts General Hospital (MGH) researchers used deep learning to analyze how genetics could impact aorta size. According to researchers, the...

How CVS Health Uses NCCN Guidelines to Advance Precision Medicine

by Erin McNemar, MPA

Organizations are constantly looking for ways to enhance treatment and patient experience. By incorporating National Comprehensive Cancer Network (NCCN) guidelines and precision medicine, CVS Health is working to improve cancer patient...

Identifying Chronic Disease Risks Through Genetic Research

by Erin McNemar, MPA

Through collecting data for the Mass General Brigham Biobank, researchers found that three-quarters of biobank participants carrying genetic risks for cancer and heart disease had never been...

Using Genetic Data For Developing Personalized Cancer Therapies

by Erin McNemar, MPA

Indiana University researchers launched a new study to create personalized therapy for patients with triple-negative breast cancer based on genetic data. According to researchers, risk stratification...